Your hub to the latest Knowledge in Nuclear Medicine/Molecular Imaging

Press releases

Hermes Medical Solutions Releases a New Version of its Molecular Imaging Software HERMIA in North America

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, launches the latest version of its HERMIA Multimodality Viewing Software, in Canada and in the USA. 

Hermes Medical Solutions is happy to announce its donation of molecular imaging/nuclear medicine software to Regis College.

“We see it as part of our mission as a leading provider of Molecular Imaging Software to provide the future generation of nuclear medicine professionals with the latest tools, especially as this area of medicine is evolving at a rapid pace and needs to attract specialized professionals,” said Tom Francke, CEO at Hermes Medical Solutions.

Hermes Medical Solutions is proud to introduce HERMIA, a new version of its all-in-one molecular imaging software

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, is now introducing HERMIA, a new version of its ALL-IN-ONE Molecular Imaging Software with many exciting functionality updates.

Scientific publications

Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.

The aim of this study was to compare reprojected bone SPECT/CT (RBS) against planar bone scintigraphy (BS) in the detection of bone metastases in breast and prostate cancer patients.

Total Tumor Volume on F18-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with Ac.225-PSMA-I&T

PSMA-based alpha therapy using 225Ac-PSMA-I&T provides treatment for metastatic castration-resistant prostate cancer (mCRPC), even after the failure of 177Lu-PSMA radioligand therapy (RLT). In clinical routine, the total tumor volume (TTV) on PSMA PET impacts therapy outcomes and plays an increasing role in mCRPC patients. Hence, we aimed to assess TTV and its changes during 225Ac-PSMA-I&T RLT.

Comparing calculated and experimental activity and dose values obtained from image-based quantification of Y-90 SPECT/CT Data.

Selective internal radiation therapy (SIRT) is a treatment for various kinds of liver tumours by injecting Y-90 bearing microspheres into the liver vessels. To perform meaningful post-treatment dosimetry, quantitative imaging is performed.


Theranostics Brochure

Brochure dedicated to the advanced tools for Theranostics and Therapies within the Hermia software.

Hermia product overview

Product overview of Hermia, a state-of-the-art software suite that supports all clinical scenarios in NM/MI on all cameras.

Future Liver Remnant Function

Ensure the best outcome for your patients undergoing major liver resection

White papers

Hermia SPECT Reconstruction

The quality of SPECT imaging is reduced by photon attenuation, resolution loss due to collimator-detector blur, photon scatter, and noise. All these factors limit both the visual quality and quantitative power of SPECT images. Hermia SPECT Reconstruction provides methods to compensate for the effects of the aforementioned four factors by modelling them in iterative reconstruction.

Hermia Advanced Bone SPECT Reconstruction

With easy-to-use software enabling precise determination of reconstruction parameters, we are proud to offer several Bayesian reconstruction algorithms to optimise your bone SPECT/CT images, including two algorithms leveraging the information from the CT to guide the SPECT reconstruction, namely AMAP-Smooth and AMAP-RDP. AMAP-RDP showed superior performance to all other tested reconstruction algorithms in the study by Kangasmaa et. al. (1)